Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells
Journal of Innate Immunity · 2024
DOI: 10.1159/000535634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innate Immunity, 2024. Verfasst von Rahul Dilawari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbial Technology, CSIR, Chandigarh, India. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19, Protein Binding. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Coronavirus disease 2019 caused by coronavirus-2 (SARS-CoV-2) has emerged as an aggressive viral pandemic. Health care providers confront a challenging task for rapid development of effective strategies to combat this and its long-term after effects. Virus entry into host cells involves interaction between receptor-binding domain (RBD) of spike (S) protein S1 subunit with angiotensin converting enzyme present on host cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a moonlighting enzyme involved in cellular glycolytic energy metabolism and micronutrient homeostasis. It is deployed in various cellular compartments and the extra cellular milieu. Though it is known to moonlight as a component of mammalian innate immune defense machinery, till date its role in viral restriction remains unknown.
Method
Recombinant S protein, the RBD, and human GAPDH protein were used for solid phase binding assays and biolayer interferometry. Pseudovirus particles expressing four different strain variants of S protein all harboring ZsGreen gene as marker of infection were used for flow cytometry-based infectivity assays.
Results
Pseudovirus entry into target cells in culture was significantly inhibited by addition of human GAPDH into the extracellular medium. Binding assays demonstrated that human GAPDH binds to S protein and RBD of SARS-CoV-2 with nanomolar affinity.
Conclusions
Our investigations suggest that this interaction of GAPDH interferes in the viral docking with hACE2 receptors, thereby affecting viral ingress into mammalian cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microbial Technology, CSIR, Chandigarh, India.
- National Institute of Pharmaceutical Education and Research, Sahibzada Ajit Singh Nagar, India.
Zitieren
APA
Dilawari, R., Chaubey, G. K., Modanwal, R., Dhiman, A., Talukdar, S., Kumar, A., Raje, C. I., & Raje, M. (2024). Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells. Journal of Innate Immunity. https://doi.org/10.1159/000535634
Vancouver
Dilawari R, Chaubey GK, Modanwal R, Dhiman A, Talukdar S, Kumar A, et al. Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells. Journal of Innate Immunity. 2024. doi:10.1159/000535634
BibTeX
@article{Dilawari2024,
author = {Dilawari, Rahul and Chaubey, Gaurav Kumar and Modanwal, Radheshyam and Dhiman, Asmita and Talukdar, Sharmila and Kumar, Ajay and Raje, Chaaya Iyengar and Raje, Manoj},
title = {Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells},
journal = {Journal of Innate Immunity},
year = {2024},
doi = {10.1159/000535634}
}
EUVIMED